Without wanting to dwell on it too much Patrolly.
Do you think the updated trial data would have been obtained by the company at about the time you suggested there would be an update (mid Feb).
Would it be possible the time required for the data to be verified, collated ready for presentation would take a week or two. That puts the time line very close to the next big show. World Immunotherapy Congress USA 20193-5 March 2019. Soon followed by the ECCO gathering and presentation. Just seems plausible to me.
I don’t want to wish time away, but considering the interesting daily market volumes by this time next week it may be more than interesting. Much more. GLTA
Big Year Ahead, page-74
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
